PRESS RELEASE: Aging published a new review paper in Volume 15, Issue 4, entitled, “Cellular senescence: when growth stimulation meets cell cycle arrest.”
Aging-US Authors
PRESS RELEASE: Dr. Blagosklonny published a new research perspective in Aging’s Volume 15, Issue 2, entitled, “Are menopause, aging and prostate cancer diseases?”
PRESS RELEASE: A new research perspective was published on October 24, 2022, in Aging’s Volume 14, Issue 20, entitled, “Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice.”
Dennis Mangan and Dr. Mikhail Blagosklonny discuss how Dr. Blagosklonny’s cancer research led him to the study of aging, whether rapamycin is the most important anti-aging intervention currently available, his skepticism about metformin as an anti-aging drug, and more.
Dennis Mangan from MTOR LLC in Bakersfield, California details his theory article published by Aging (Aging-US), entitled, “Iron: an underrated factor in aging.”
PRESS RELEASE: Dr. Mikhail Blagosklonny published a new review paper in Aging (Aging-US), entitled, “Hallmarks of cancer and hallmarks of aging.”
PRESS RELEASE: Mikhail Blagosklonny, M.D., Ph.D., published a new research perspective about upcoming research at Altos Labs.
Following the Second Interventions in Aging Conference, meeting organizers Dr. Brian Kennedy and Dr. Linda Partridge discuss their overview of the meeting proceeding.
Dr. Michael Lisanti describes his 2020 paper published by Aging, entitled, “COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?”
Dr. Marina Antoch from Roswell Park Comprehensive Cancer Center discusses her 2017 study published by Aging, entitled: “Physiological frailty index (PFI): quantitative in-life estimate of individual biological age in mice.”